Document Detail

Percutaneous intervention for atherosclerotic disease in saphenous vein grafts.
MedLine Citation:
PMID:  12007681     Owner:  NLM     Status:  MEDLINE    
The long term benefit of coronary artery bypass surgery (CABG) is limited by development of atherosclerotic disease in the bypass conduits. Percutaneous revascularisation is frequently the preferred method of treated symptomatic saphenous vein graft (SVG) atherosclerotic disease. The immediate and long term results of percutaneous intervention for SVGs is reviewed. Therapeutic considerations as well as novel technical advances are overviewed
Niall T Mulvihill; Jean Marco
Publication Detail:
Type:  Journal Article; Review    
Journal Detail:
Title:  International journal of cardiology     Volume:  83     ISSN:  0167-5273     ISO Abbreviation:  Int. J. Cardiol.     Publication Date:  2002 May 
Date Detail:
Created Date:  2002-05-14     Completed Date:  2002-07-22     Revised Date:  2007-11-15    
Medline Journal Info:
Nlm Unique ID:  8200291     Medline TA:  Int J Cardiol     Country:  Ireland    
Other Details:
Languages:  eng     Pagination:  103-10     Citation Subset:  IM    
Unite de Cardiologie Interventionnelle, Clinique Pasteur, 45 Avenue de Lombez, 31076, Toulouse, France.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Angioplasty, Transluminal, Percutaneous Coronary / methods*
Coronary Angiography
Coronary Artery Bypass / adverse effects*,  methods
Coronary Artery Disease / therapy*
Coronary Stenosis / surgery*
Graft Rejection / therapy*
Risk Assessment
Saphenous Vein / transplantation*
Survival Rate
Treatment Outcome

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Elevated serum S100B protein in drug-free bipolar patients during first manic episode: a pilot study...
Next Document:  Value of intracardiac ultrasound in the diagnosis of arrhythmogenic right ventricular dysplasia-card...